Obese chronic kidney disease diabetic’s patients: Malignant tumours
Global Journal of Obesity, Diabetes and Metabolic Syndrome · 2017
DOI: 10.17352/2455-8583.000025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Global Journal of Obesity, Diabetes and Metabolic Syndrome, 2017. Verfasst von N Esparza Martín. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Patients with chronic kidney disease (CKD) have a high incidence of malignant tumours. Purpose of the study: Prospective observational study of factors present at initial evaluation of stage 3 CKD patients proceeding from external consultations after two years of follow-up. Exclusion criteria: Under 40 or mayor 79 years old, anaemia, previous heart or hepatic failure, valvular or isquemic cardiopathy, arrhythmias, clinical arterial peripheral disease or immunosuppressive treatment. Inclusion criteria: All the incidental patients who wish to participated between January, 2012 and January, 2014. The study was approved by the Committee of Ethics of Clinical Investigation.
Zitieren
APA
Martín, N. E. (2017). Obese chronic kidney disease diabetic’s patients: Malignant tumours. Global Journal of Obesity, Diabetes and Metabolic Syndrome. https://doi.org/10.17352/2455-8583.000025
Vancouver
Martín NE. Obese chronic kidney disease diabetic’s patients: Malignant tumours. Global Journal of Obesity, Diabetes and Metabolic Syndrome. 2017. doi:10.17352/2455-8583.000025
BibTeX
@article{Martn2017,
author = {Martín, N Esparza},
title = {Obese chronic kidney disease diabetic’s patients: Malignant tumours},
journal = {Global Journal of Obesity, Diabetes and Metabolic Syndrome},
year = {2017},
doi = {10.17352/2455-8583.000025}
}
EUVIMED